secwatch.observer — SEC 8-K summary
======================================

Issuer:     LUDWIG ENTERPRISES, INC. (LUDG)
CIK:        0001960262
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001213900-25-040453
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ludwig previews Revealia Breast™ cheek-swab test; Q3 2025 launch expected
-------------------------------------------------------------------------

- Revealia Breast™ uses mRNA biomarkers and AI from a cheek swab for early cancer detection.
- Test is in advanced development with expected release in Q3 2025.
- Cites ASBS study: 39.7% non-invasive disease vs 13.2% with traditional management.
- First in pipeline of non-invasive mRNA-based cancer screening tests targeting major cancers.
- No financial data or revenue projections provided in the release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1960262/000121390025040453/0001213900-25-040453-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1960262/000121390025040453/ea0240968-8k_ludwig.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-040453

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer